KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShare-based Compensation (IS)Share-based Compensation (IS)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

BioNTech SE (BNTX) Tax Provisions (2018 - 2025)

BioNTech SE's Tax Provisions history spans 8 years, with the latest figure at $90.3 million for Q4 2025.

  • On a quarterly basis, Tax Provisions rose 102.71% to $90.3 million in Q4 2025 year-over-year; TTM through Dec 2025 was $139.8 million, a 29.34% increase, with the full-year FY2025 number at $96.4 million, up 627.31% from a year prior.
  • Tax Provisions hit $90.3 million in Q4 2025 for BioNTech SE, up from $62.4 million in the prior quarter.
  • Over the last five years, Tax Provisions for BNTX hit a ceiling of $3.8 billion in Q3 2021 and a floor of -$912.0 million in Q4 2022.
  • Historically, Tax Provisions has averaged $344.8 million across 5 years, with a median of $30.7 million in 2024.
  • Biggest five-year swings in Tax Provisions: skyrocketed 920631037.69% in 2021 and later crashed 271.62% in 2025.
  • Tracing BNTX's Tax Provisions over 5 years: stood at $1.8 billion in 2021, then crashed by 151.51% to -$912.0 million in 2022, then skyrocketed by 124.22% to $220.9 million in 2023, then plummeted by 79.83% to $44.6 million in 2024, then soared by 102.71% to $90.3 million in 2025.
  • Business Quant data shows Tax Provisions for BNTX at $90.3 million in Q4 2025, $62.4 million in Q3 2025, and $18.2 million in Q2 2025.